Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningMultiple MyelomaHematopoietic Stem Cell MobilizationKidney TransplantationTreatment OutcomeRecurrenceHodgkin DiseaseLiver TransplantationStem Cell TransplantationGraft SurvivalSurvival AnalysisRetrospective StudiesMelphalanHeart TransplantationPeripheral Blood Stem Cell TransplantationCombined Modality TherapyBlood Transfusion, AutologousLung TransplantationCell TransplantationLymphoma, Non-HodgkinGraft RejectionBone Marrow PurgingSalvage TherapyAntigens, CD34Immunosuppressive AgentsCarmustineGraft vs Host DiseaseCyclophosphamideWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsLeukapheresisTransplantationGranulocyte Colony-Stimulating FactorRemission InductionHematopoietic Stem CellsTime FactorsDisease-Free SurvivalEtoposideBusulfanHematologic NeoplasmsSurvival RateTransplantsTransplantation ImmunologyFollow-Up StudiesOrgan TransplantationCytarabineIslets of Langerhans TransplantationMyeloablative AgonistsLiving DonorsGraft vs Tumor EffectPancreas TransplantationTransplantation ChimeraBone MarrowTissue and Organ ProcurementImmunosuppressionTransplantation, IsogeneicPrognosisThalidomidePostoperative ComplicationsTransplantation, HeterotopicFeasibility StudiesCells, CulturedVincristineKanamycin KinaseBlood Component RemovalHistocompatibility TestingHeart-Lung TransplantationLymphomaCell SeparationLeukemiaCord Blood Stem Cell TransplantationFetal Tissue TransplantationHematopoiesisCyclosporinePrednisoneProspective StudiesBone Marrow CellsNeoplasm, ResidualLeukemia, Myeloid, AcuteTacrolimusGenetic TherapyWaiting ListsAntineoplastic Agents, AlkylatingLiver FailureTransplantation ToleranceIdarubicinColony-Forming Units AssayMyelodysplastic SyndromesStem CellsAntibodies, MonoclonalDexamethasoneBlood Cell CountT-LymphocytesImmunomagnetic SeparationCell Culture Techniques